Liferay Portal Vulnerable to Cross-Site Scripting
A reflected cross-site scripting (XSS) vulnerability in the Liferay Portal 7.4.3.132, and Liferay DXP 2025.Q1.0 through 2025.Q1.7 allows a remote authenticated attacker to inject JavaScript code via the content page's name field. This malicious payload is then reflected and executed within the user's browser when viewing the "document View Usages" page.
Liferay Portal is fixed on the master branch from commit 2135a88.
Affected software
Click a technology to see all vulnerabilities affecting it.
| Platform | Package | Vulnerable versions | Fixed in |
|---|---|---|---|
| Java / Kotlin (Maven) | com.liferay:com.liferay.layout.taglib | < 17.0.0 | 17.0.0 |
References
- https://nvd.nist.gov/vuln/detail/CVE-2025-43733
- https://github.com/liferay/liferay-portal/commit/2135a88adb8c7f1a6cb4fbd768fef3b08953a50c
- https://github.com/liferay/liferay-portal
- https://liferay.atlassian.net/browse/LPE-18218
- https://liferay.dev/portal/security/known-vulnerabilities/-/asset_publisher/jekt/content/CVE-2025-43733
- CVSS vector
CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N- Weakness (CWE)
CWE-79- Platform
- Java / Kotlin (Maven)
- Package
com.liferay:com.liferay.layout.taglib- Disclosed
- 18.08.2025
- Updated
- 11.10.2026 12:22
Sources and licenses
OSV / GitHub Advisory Database - GHSA-vhcr-hgc8-29qr - CC BY 4.0
Vulnerability history: com.liferay:com.liferay.layout.taglib
All published vulnerabilities of this package (Java / Kotlin (Maven)), newest first. Shows whether this is a one-off slip or a package that needs watching.
- Total entries
- 2
- First → latest
- 08.2025 08.2025
- Without a fix
- 0
- Exploited in attacks
- 0
Severity breakdown
- Low 2
Disclosures per year
- 2025: 2
- 2026: 0
-
Liferay Portal Vulnerable to Cross-Site Scripting this entry
Know which vulnerabilities affect your application
With the DockRay integration and software inventory enabled, DockRay checks reported component versions against known vulnerabilities and notifies you about confirmed matches. Coverage depends on the supported technology and available advisory data.